Physician profile
Michael B Wert
NPI 1558310276
$412,133.05
in general payments reported to CMS, 2019-2025
44 companies · $53K in 2025
The $53K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $54K · 2021: $145K · 2022: $41K · 2023: $40K · 2024: $43K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $120K · Food and Beverage: $9,440 · Travel and Lodging: $6,212 · Education: $61.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $120,117.50 |
| Food and Beverage | $9,439.50 |
| Travel and Lodging | $6,211.56 |
| Education | $61.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $319,001.08 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Mylan Specialty L.P. | $65,563.42 | 2019-2024 | Yupelri, Yupelri |
| Glaxosmithkline, LLC. | $17,428.18 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Viatris Specialty LLC | $2,009.42 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,279.43 | 2019-2025 | Ofev, Jardiance, Jascayd |
| United Therapeutics Corporation | $723.83 | 2020-2025 | Tyvaso, Tyvaso, Orenitram |
| Insmed, INC. | $602.75 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $535.97 | 2020-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $483.53 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $450.72 | 2019-2024 | |
| Grifols USA, LLC | $325.04 | 2019-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $321.98 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $314.75 | 2019-2025 | Dificid, Zerbaxa, Winrevair |
| Actelion Pharmaceuticals US, INC. | $309.16 | 2019-2025 | Uptravi, Opsumit |
| Verona Pharma, INC. | $238.26 | 2025 | Ohtuvayre |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $236.29 | 2019-2020 | |
| Electromed, INC. | $228.48 | 2019-2024 | Smartvest |
| Philips North America LLC | $212.38 | 2019-2023 | |
| Genentech USA, INC. | $191.10 | 2019 | |
| Abbvie INC. | $148.71 | 2021-2024 | Teflaro, Avycaz |
| Amgen INC. | $140.91 | 2021-2024 | Tezspire |
| Circassia INC. | $139.37 | 2019-2020 | |
| Baxter Healthcare | $130.42 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $116.45 | 2022-2024 | Inogen |
| Teva Pharmaceuticals USA, INC. | $110.03 | 2021-2023 | |
| Harmony Biosciences LLC | $108.95 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $103.87 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $89.97 | 2019-2020 | |
| Shionogi INC | $87.67 | 2022-2024 | Fetroja |
| La Jolla Pharmaceutical Company | $77.73 | 2019-2022 | |
| Breas Medical, INC. | $61.47 | 2024 | Vivo 45 Ls |
| Mallinckrodt Hospital Products INC. | $58.49 | 2020-2023 | Acthar |
| Allergan, INC. | $56.27 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $39.83 | 2025 | Voquezna |
| Tersera Therapeutics LLC | $33.48 | 2022 | |
| Exact Sciences Corporation | $30.55 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $24.63 | 2019-2022 | |
| Alcresta Therapeutics, INC. | $22.94 | 2025 | Relizorb |
| Bard Peripheral Vascular, INC. | $20.95 | 2020 | |
| Novo Nordisk INC | $19.26 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $18.32 | 2024 | Lumryz |
| Pulmonx Corporation | $13.38 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $11.95 | 2022 | |
| Quidel Corporation | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.